1 December 2015 - UnitedHealth Group Inc.’s Oxford unit, which runs health plans in the northeastern U.S., will favor Sanofi and Regeneron Pharmaceuticals Inc.’s new cholesterol-cutting shot Praluent over a similar treatment made by Amgen Inc.

For more details, go to: http://www.bloomberg.com/news/articles/2015-11-30/unitedhealth-unit-favors-cholesterol-drug-from-sanofi-regeneron